<DOC>
	<DOCNO>NCT01132690</DOCNO>
	<brief_summary>This multi-center , double-blind trial ass safety efficacy taliglucerase alfa untreated subject ( 2 &lt; 18 year old ) Gaucher disease randomly assign treatment one two dos , 30 60 units/kg . Subjects receive intravenous ( IV ) infusion taliglucerase alfa every two week . The total duration treatment 12 month . At end 12-month treatment period eligible subject offer enrollment open-label extension study taliglucerase alfa commercially available .</brief_summary>
	<brief_title>A Safety Efficacy Study Two Dose Levels Taliglucerase Alfa Pediatric Subjects With Gaucher Disease</brief_title>
	<detailed_description />
	<mesh_term>Gaucher Disease</mesh_term>
	<criteria>Males females 2 &lt; 18 year old . Diagnosis Gaucher disease leukocyte acid βglucosidase activity ≤30 % mean reference range healthy subject . Subjects receive enzyme replacement therapy ( ERT ) past receive ERT past 12 month negative antiglucocerebrosidase antibody assay . Subjects receive substrate reduction therapy ( SRT ) past 12 month . Subjects whose clinical condition , opinion investigator , require treatment enzyme replacement therapy ( ERT ) . Currently take another investigational drug condition . Presence neurological sign symptom characteristic Gaucher disease complex neuronopathic feature longstanding oculomotor gaze palsy . Presence unresolved anemia due iron , folic acid , vitamin B12 deficiency Previous hypersensitivity reaction Cerezyme® ( imiglucerase ) Ceredase® ( alglucerase ) . History allergy carrot . Presence HIV , HBsAg hepatitis C infection . Subject 's parent ( ) legal guardian ( ) unable understand nature , scope possible consequence study . Presence medical , emotional , behavioral psychological condition judgment Investigator would interfere subject 's compliance requirement study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>gaucher disease</keyword>
	<keyword>pediatric</keyword>
</DOC>